Growing Antibody Industry in China Sees Major Opportunities
Yet, Challenges Remain as Companies Need More Talent and Resources to Market Globally
Molecular Diagnostics Brings Patients Hope
NGS Advancements Pave the Way for New Drug-Resistance Research
BioTrinity Conference Focuses on NextGen Healthcare
Meeting Highlights Array of Technologies and Promising Methodologies
Supplement: CRISPR in the Courthouse
An Interview with Law Professor Jacob Sherkow
For full access to this article login to GEN Select now.
Rapid Bioprocess Culture Characterization
System Designed to Enable Real-Time Monitoring of Microbial Cultures
- Microbial expression systems such as Escherichia coli (E. coli) are still a popular choice for biotherapeutic production. Lower manufacturing costs, high-productivity rates, and their FDA-approved status for human applications make E. coli an attractive, economical option for Fab, vaccine, and peptide hormone therapies. Over 30 E. coli -derived ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.